Drug-labels.com

J07A Bacterial vaccines

ATC class of level 3 – pharmacological subgroup

This page lists the patient medication information or the product monograph for 29 drugs in this drug class and its subclasses.

Place in the ATC system

  1. J Antiinfectives for systemic use 1,101 drugs
    1. J07 Vaccines 119 drugs
      1. J07A Bacterial vaccines 29 drugs
        1. J07AC Anthrax vaccines 1 drug
        2. J07AE Cholera vaccines 2 drugs
        3. J07AG Haemophilus influenzae B vaccines 4 drugs
        4. J07AH Meningococcal vaccines 7 drugs
        5. J07AJ Pertussis vaccines 3 drugs
        6. J07AL Pneumococcal vaccines 8 drugs
        7. J07AM Tetanus vaccines 1 drug
        8. J07AP Typhoid vaccines 3 drugs

The most common active ingredients of the class

… and 29 other active ingredients in fewer drugs.

Drugs in the class and its subclasses

DrugRx or OTC
Act-Hib (J07AG01 Hemophilus influenzae b, purified antig. conjugated) –
Actacel PM (J07AG52 Hemophilus influenzae b, combinations with pertussis and toxoids) –
Actacel Hybrid (J07AG52 Hemophilus influenzae b, combinations with pertussis and toxoids) –
Adacel (J07AJ52 Pertussis, purified antigen, comb. with toxoids) –
Bexsero PM (J07AH09 Meningococcus b, multicomponent vaccine) –
Biothrax PM (J07AC01 Anthrax antigen) –
Capvaxive PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Dukoral PM (J07AE01 Cholera, inactivated, whole cell) –
Hiberix PM (J07AG51 Hemophilus influenzae b, combinations with toxoids) –
Menactra PM (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Menomune-A/C/Y/W-135 PM (J07AH04 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen) –
Menquadfi (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Menveo PM (J07AH08 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen conjugated) –
Neisvac-C (J07AH07 Meningococcus c, purified polysaccharides antigen conjugated) –
Nimenrix PM (J07AH04 Meningococcus, a, c, y, W-135, tetraval. purified polysacc. antigen) –
Pneumovax 23 -(5-Dose) PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Pneumovax 23 (Merck Canada, PM 00035855) PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Pneumovax 23 (Merck Canada, PM 00075041) PM (J07AL01 Pneumococcus, purified polysaccharides antigen) –
Prevnar 13 PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Prevnar 20 PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Synflorix PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Td Adsorbed PM (J07AM51 Tetanus toxoid, comb. with diphtheria toxoid) –
Tripacel PM (J07AJ52 Pertussis, purified antigen, comb. with toxoids) –
Tripacel Hybrid (J07AJ52 Pertussis, purified antigen, comb. with toxoids) –
Typherix PM (J07AP03 Typhoid, purified polysaccharide antigen) –
Typhim VI (J07AP03 Typhoid, purified polysaccharide antigen) –
Vaxchora PM (J07AE02 Cholera, live attenuated) –
Vaxneuvance PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) –
Vivotif PM (J07AP01 Typhoid, oral, live attenuated) –

Other classes of the same level

Other names of the drug class

Sources

  • Patient medication information and product monographs: Health Canada, Drug Product Database
  • Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
  • World Health Organization (WHO): ATC/DDD system, class J07A

Ask your doctor or pharmacist for advice.